Agentic AI for CRO Services
Maxis AI provides Agentic AI for CRO Services through supervised execution, enabling AI-enabled CRO delivery services across study startup, clinical data management, operational oversight, biometrics, and regulatory workflows.
How Agentic AI for CRO Services Supports the Entire Delivery Lifecycle
Study Startup Support
Accelerate protocol review, IRB submissions, site activation, and startup execution using Agentic AI for CRO Services.
Clinical Data Management
AI-enabled CRO delivery services for clinical data review, quality oversight, and RBQM execution.
Statistical Programming Support
Predictive risk detection with autonomous investigation.
Operational Oversight
AI-guided operational oversight across multiple studies, sponsors, and sites.
AI-guided early-phase execution
AI-guided early-phase execution under human-in-the-loop oversight.
Unlike traditional analytics platforms that stop at visibility, Maxis' Agentic AI for CRO Services executes governed operational workflows under human-in-the-loop validation and audit traceability — improving delivery consistency while preserving governance.
Built for the leaders behind CRO delivery.
COOs / Heads of Clinical Delivery
Improve predictability and scale delivery models.
VPs of Clinical Operations
Reduce startup delays and enrollment risk.
CFOs
Improve cost control and margins.
Biometrics Leaders
Increase execution consistency across data review and submission-readiness workflows.
Where AI-enabled CRO Delivery Services Create the Biggest Operational Impact
Contract research organizations, from global CRO delivery portfolios to growing regional teams, often struggle with fragmented execution across startup, data review, operational oversight, and regulatory workflows. The constraint is rarely headcount—it is coordinated execution capacity.
The constraint is not effort — it is scalable execution capacity and orchestration.
- Prolonged IRB drafting and revision cycles
- Fragmented oversight across EDC, CTMS, and eTMF systems
- Reactive risk detection after milestone slippage
- Escalation-heavy coordination across sponsors and sites
- Enrollment forecasting variability
Business Outcomes of Agentic AI for CRO Services
Organizations adopting Agentic AI for CRO Services improve delivery consistency, operational predictability, compliance, and study execution quality — including smaller CROs scaling biometrics capacity without proportional headcount.
Compressed startup timelines
Standardized IRB and submission coordination
Proactive risk signal identification
Reduced manual follow-up and escalation dependency
Consistent audit traceability across workflows
Improved milestone predictability across portfolios
Phase 1 Trial: Protocol to Database Lock in 9–12 Months. Trial cost under $400K
Maxis AI helped an oncology biotech accelerate study startup by 45% through one governed Phase 1 execution model - from protocol through database lock.
45%
Faster startup
2–3x
Enrollment conversion
40-50%
Faster DB lock
<$400K
Fixed price vs $2–5M
All You Need to Know
Agentic AI for CRO Services uses supervised AI agents to execute structured clinical operations across study startup, data management, operational oversight, statistical programming, and regulatory workflows. Unlike conventional automation that performs isolated tasks, the AI Workforce carries out governed execution within defined workflow boundaries while maintaining human validation checkpoints and complete audit traceability. This enables CROs to improve delivery consistency, scale execution capacity, and support sponsor commitments without replacing existing teams or validated processes.
Agentic AI for CRO Services improves clinical trial delivery by executing operational work that typically delays studies, including study startup coordination, data cleaning, query resolution, programming support, and workflow follow-up. Rather than simply identifying risks, supervised AI agents help resolve them within governed workflows and under human oversight. These AI-enabled CRO delivery services increase execution capacity, improve milestone predictability, reduce repetitive manual work, and help CROs maintain consistent delivery quality across multiple sponsors and clinical studies.
Yes. Agentic AI for CRO Services is designed to work within existing CRO technology ecosystems, including sponsor-mandated platforms and validated clinical systems. The AI Workforce executes governed workflows without requiring organizations to replace their EDC, CTMS, eTMF, or other operational platforms. This allows CROs to preserve previous technology investments while adding supervised execution that improves throughput, coordination, and operational efficiency across clinical programs.
Maxis AI provides AI-enabled CRO delivery services across the clinical trial lifecycle. These include AI Accelerated Startup and IRB for study startup and site activation, the AI Data Quality and RBQM Hub for data quality oversight and risk-based quality management, and the Phase 1 Accelerator for protocol-to-database-lock execution. Each solution operates with supervised execution, defined workflow permissions, human validation checkpoints, and complete audit traceability to support regulated clinical trial delivery.
Agentic AI for CRO Services reduces repetitive operational work by executing routine activities such as query handling, dataset preparation, document assembly, reconciliation, and workflow coordination within predefined governance boundaries. Human experts continue to supervise execution and validate outputs at critical decision points, ensuring accountability and regulatory oversight. This approach expands execution capacity, improves cycle-time consistency, reduces operational backlogs, and enables CRO teams to focus on higher-value scientific and sponsor-facing activities.
Explore the Agentic AI Platform.
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.